Metallothionein isoform expression by breast cancer cells

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 8, 2000, Pages 895-903

  Barnes, Natalie L ^a   Ackland, M Leigh ^a   Cornish, E Jean ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

Competitive RT PCR; Copper and zinc resistance; Estrogen receptor positive; Metallothionein isoforms; PMC42 breast cancer cells

Indexed keywords

COPPER; ESTROGEN RECEPTOR; ISOPROTEIN; METALLOTHIONEIN; ZINC;

ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ONCOGENE; PROTEIN EXPRESSION;

BREAST NEOPLASMS; COPPER; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, AGAR GEL; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METALLOTHIONEIN; METALS; PROTEIN ISOFORMS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; ZINC;

EID: 0034255463     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(00)00024-8     Document Type: Article

References (31)

1. Abdel-Mageed A., Agrawal K.C. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther. 4:1997;199-207.
2. Abdel-Mageed A., Agrawal K.C. Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response. Cancer Res. 58:1998;2335-2338.
3. Ackland M.L., Cornish E.J., Paynter J.A., Grimes A., Michalczyk A., Mercer J.F.B. Expression of Menkes disease gene in mammary carcinoma cells. Biochem. J. 328:1997;237-243.
4. Beach L.R., Palmiter R.D. Amplification of the metallothionein-I gene in cadmium-resistant mouse cells. Proc. Natl. Acad. Sci. USA. 78:1981;2110-2114.
5. Cousins R.J. Absorption, transport and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol. Rev. 65:1985;238-303.
6. Czaja M.J., Weiner F.R., Freedman J.H. Amplification of the metallothionein-1 and metallothionein-2 genes in copper-resistant hepatoma cells. J. Cell. Physiol. 147:1991;434-438.
7. Douglas-Jones A.G., Schmid K.W., Bier B., Horgan K., Lyons K., Dallimore N.D., Moneypenny I.J., Jasani B. Metallothionein expression in duct carcinomas of the breast. Hum. Pathol. 26:1995;217-222.
8. Douglas-Jones A.G., Navabi H., Morgan J.M., Jasani B. Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast. No correlation. Virchows Arch. 430:1997;373-379.
9. Durnam D.M., Palmiter R.D. Transcriptional regulation of the mouse metallothionein-I gene by heavy metals. J.Biol.Chem. 256:1981;5712-5716.
10. Fresno M., Wu W., Rodriguez J.M., Nadji M. Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Arch. A. Pathol. Anat. Histopathol. 423:1993;215-219.
11. Friedline J.A., Garrett S.H., Somji S., Todd J.H., Sens D.A. Differential expression of the MT-1E gene in estrogen-receptor positive and -negative breast cancer cell lines. Am. J. Pathol. 152:1998;23-27.
12. Ganguly S., Taioli E., Baranski B., Cohen B., Toniolo P., Garte S.J. Human metallothionein gene expression determined by quantitative reverse transcription-polymerase chain reaction as a biomarker of cadmium exposure. Cancer Epidemiol. Biomarkers. Prev. 5:1996;297-301.
13. Garrett S.H., Somji S., Todd J.H., Sens M.A., Sens D.A. Differential expression of human metallothionein isoform I mRNA in human proximal tubules cells. Environ. Health. Perspect. 106:1998;825-832.
14. Gilliland G., Perrin S., Blanchard K., Bunn H.F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. U.S.A. 87:1990;2725-2729.
15. Goulding H., Jasani B., Pereira H., Reid A., Galea M., Bell J.A., Elston C.W., Robertson J.F., Blamey R.W., Nicholson R.A., Schmid K.W., Ellis I.O. Metallothionein expression in human breast cancer. Br. J. Cancer. 72:1995;968-972.
16. Haerslev T., Jacobsen K., Nedergaard L., Zedeler K. Immunochemical detection of metallothionein in primary breast carcinomas. Pathol. Res. Pract. 190:1994;675-681.
17. Hurnanen D., Chan H.M., Kubow S. The protective effect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells. J. Pharmacol. exp. Ther. 283:1997;1520-1528.
18. Jahroudi N., Foster R., Price-Haughey J., Beitel G., Gedamu l. Cell-type specific and differential regulation of the human metallothionein genes. Correlation with DNA methylation and chromatin structure. J. Biol. Chem. 265:1990;6506-6511.
19. Jasani B., Campbell F., Navabi H., Schmid K.W., Williams G.T. Clonal overexpression of metallothioneins is induced by somatic mutation in morphologically normal colonic mucosa. J. Pathol. 184:1998;144-147.
20. Kondo Y., Rusnak J.N., Hoyt D.G., Settineri C.E., Pitt B.R., Lazo J.S. Enhanced apoptosis in metallothionein null cells. Mol. Pharmacol. 52:1997;195-201.
21. Lazo J.S., Kuo S.-M., Woo E.S., Pitt B.R. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs. Chem. Biol. Interact. 111-112:1998;255-262.
22. Mididoddi S., McGuirt J.P., Sens M.A., Todd J.H., Sens D.A. Specific expression of metallothionein mRNA in the developing and adult human kidney. Toxicol. Lett. 85:1996;17-27.
23. Oyama T., Take H., Hikino T., Iino Y., Nakajima T. Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology. 53:1996;112-117.
24. Sadhu C., Gedamu L. Metal-specific posttranscriptional control of human metallothionein genes. Mol. Cell. Biol. 9:1989;5738-5741.
25. Schmid K.W., Ellis I.O., Gee J.M., Darke B.M., Lees W.E., Kay J., Cryer A., Stark J.M., Hittmair A., Ofner E., et al. Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch. A. Pathol. Anat. Histopathol. 422:1993;153-159.
26. Sullivan V.K., Cousins R.J. Competitive reverse transcriptase-polymerase chain reaction shows that dietary zinc supplementation in humans increases monocyte metallothionein mRNA levels. J. Nutr. 127:1997;694-698.
27. Wan M., Heuchel R., Radtke F., Hunziker P.E., Kagi J.H. Regulation of metallothionein gene expression in Cd- or Zn- adapted RK-13 cells. Experientia. 51:1995;606-611.
28. Whitehead R.H., Bertoncello I., Webber L.M., Pedersen J.S. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization. JNCI. 70:1983;649-661.
29. Whitehead R.H., Monaghan P., Webber L.M., Bertoncello I., Vitali A.A. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. II. Characterization of cells growing as organoids. JNCI. 71:1983;1193-1203.
30. Whitehead R.H., Quirk S.J., Vitali A.A., Funder J.W., Sutherland R.L., Murphy L.C. A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. JNCI. 73:1984;643-648.
31. Woo E.S., Monks A., Watkins S.C., Wang A.S., Lazo J.S. Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel. Cancer Chemother. Pharmacol. 41:1997;61-68.